CAPS Medical is a medical device company focused on development and commercialization of a minimally invasive and selective cancer treatment using Cold Atmospheric Plasma, applicable for a wide range of solid tumors.

​

CAPS Medical was founded following extensive scientific research as a collaboration between the Technion’s Plasma Lab and Rambam Medical Center’s Cancer Lab, united in the fight against cancer. The company is addressing an unmet need in the multi billion dollar oncology therapeutics market.

​

​